Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04717180
Other study ID # aphasia software
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2018
Est. completion date June 20, 2020

Study information

Verified date December 2020
Source Alexandria University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Aphasia is a disorder of language processing caused by a lesion in particular brain regions. Treatment aims at improving or restoring impaired function or at compensating for deficits. More recently, computer technology has been integrated into treatment options. In this study, a detailed and comprehensive computerized software program for aphasia rehabilitation is designed for the treatment of Arabic speaking Egyptian aphasic patients. Aim of the study: design a computerized software program for the rehabilitation of Arabic speaking Egyptian aphasic patients.


Description:

Aphasia is a disorder of language processing caused by a lesion in particular brain regions. Treatment aims at improving or restoring impaired function or at compensating for deficits. More recently, computer technology has been integrated into treatment options. In this study, a detailed and comprehensive computerized software program for aphasia rehabilitation is designed for the treatment of Arabic speaking Egyptian aphasic patients. Aim of the study: design a computerized software program for the rehabilitation of Arabic speaking Egyptian aphasic patients. Subjects: The study was conducted on 50 patients with aphasia who attend the unit of Phoniatrics during the period of one year, Department of Otorhinolaryngology, Alexandria Main University Hospitals. Methodology: The training materials were designed as a software program. Each patient was subjected to assessment before and after the application of the rehabilitation program. Patients were randomized into two groups: group I who received therapy using the software aphasia rehabilitation program and group II who received conventional (traditional) language therapy. Therapy continued for 48 sessions over six months.


Recruitment information / eligibility

Status Completed
Enrollment 105
Est. completion date June 20, 2020
Est. primary completion date September 15, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Clinical diagnosis of aphasia - Age 18 years or more Exclusion Criteria: - Intellectual disabilities. - Visual impairment. - Hearing impairment. - Associated dysarthria and or apraxia of speech. - Associated psychiatric disorders

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
aphasia rehabilitation using software program or conventional therapy
Patients were randomized into two groups: group I who received therapy using the software aphasia rehabilitation program and group II who received conventional (traditional) language therapy

Locations

Country Name City State
Egypt Alexandria Main University Hospitals Alexandria

Sponsors (1)

Lead Sponsor Collaborator
Alexandria University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary The primary outcome was a measure of improvement in language abilities. The primary outcome was a measure of improvement in language abilities. It was measured (after 48 sessions) using Boston Diagnostic Aphasia Examination (BDAE) Arabic version to detect any significant improvement in language 6 months